Cartesian Therapeutics (RNAC) FCF Margin Growth (3y) (2018 - 2026)
Cartesian Therapeutics (RNAC) FCF Margin Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
10,029.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
723.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cartesian Therapeutics |
261.84 Mn |
261.84 Mn |
- |
-2.83 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-2.83 Mn |
| Dec 31, 2025 |
132,726.00 |
| Sep 30, 2025 |
-441,582.00 |
| Mar 31, 2025 |
-211,420.00 |
| Dec 31, 2024 |
65,746.00 |
| Sep 30, 2024 |
197,997.00 |
| Jun 30, 2024 |
-1,938.00 |
| Mar 31, 2024 |
-16,252.00 |
| Dec 31, 2023 |
-22,700.00 |
| Sep 30, 2023 |
-154,119.00 |
| Dec 31, 2022 |
12,170.00 |
| Jun 30, 2022 |
5.53 Mn |
| Mar 31, 2022 |
20.24 Mn |
| Dec 31, 2021 |
136,953.00 |
| Dec 31, 2020 |
7.87 Mn |
| Sep 30, 2020 |
5.69 Mn |
| Dec 31, 2019 |
-24,040.00 |
| Jun 30, 2019 |
-5.51 Mn |
| Mar 31, 2019 |
-20.19 Mn |
| Dec 31, 2018 |
-106,331.00 |
